Researchers examined data compiled by a questionnaire regarding one’s frequency of alcohol consumption. The results showed that individuals undergoing treatment for HIV experienced higher rates of mortality and physiological damage than the uninfected survey participants.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Previous studies on the increased risk of adverse alcohol-related effects in HIV patients concluded that alcohol’s interruption of the HIV care continuum could be linked to the risk increase. In this study, researchers were able to show that even patients taking their medication incurred a higher rate of harm from alcohol consumption.
Study co-author Amy Justice, MD, PhD, and former professor at the Yale School of Medicine, suggested that future research could illuminate the potential direct physiological reasons for the increase in alcohol-related harm in HIV patients.
“Even though people with HIV now are…very functional and medications are very effective, they still have a chronic disease that is taking a toll physiologically,” said Dr. Justice in the Yale Daily News.
Dr. Justice went on to suggest that recommended limits on alcohol consumption should be lowered for those infected with HIV.
More articles on quality:
New Hampshire hospitals report more ‘never events’
New study highlights difficulties in controlling neonatal postoperative bleeding
Reporting quality measures is costly, not useful for physician practices, survey finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.